Clinical Trial Update: Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs. [NA]

View source ↗

Summary

A clinical trial by Mucosa Innovations, S.L. is evaluating a novel nonhormonal vulvovaginal gel for improving symptoms related to genitourinary syndrome of meno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspareunia
• Genitourinary Syndrome of Menopause
• Overactive Bladder
• Urinary Incontinence
• Vaginal Dryness
• Vulvar Atrophy

Drugs mentioned

• Vulvovaginal Gel (nonhormonal)

Snippet

Sponsor: Mucosa Innovations, S.L. | Conditions: Vulvar Atrophy, Vulvovaginal Signs and Symptoms | NA | Status: RECRUITING